Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory W Roloff

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Genetic Counseling|January 15, 2023
Stagnation in quality of next-generation sequencing assays for the diagnosis of hereditary hematopoietic malignanciesGregory W Roloff, Reid Shaw, Timothy E O'Connor, et al.
Leukemia & Lymphoma|June 9, 2023
Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromesAdam Hamidi, Gregory W Roloff, Reid Shaw, et al.
Molecular Biology of the Cell|November 14, 2015
Locus-specific gene repositioning in prostate cancerMarc Leshner, Michelle Devine, Gregory W Roloff, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 6, 2022
Contemporary Approach to Acute Myeloid Leukemia Therapy in 2022Gregory W Roloff, Olatoyosi Odenike, Ashish Bajel, et al.
Haematologica|September 2, 2018
Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemiaLaura W Dillon, Sheida Hayati, Gregory W Roloff, et al.
Histochemistry and Cell Biology|January 22, 2016
Tissue-of-origin-specific gene repositioning in breast and prostate cancerKaren J Meaburn, Olufunmilayo Agunloye, Michelle Devine, et al.
Frontiers in Oncology|July 3, 2023
Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantationReid Shaw, Ali R Haque, Tyler Luu, et al.
Ejhaem|June 16, 2025
Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax TherapyRafael Madero-Marroquin, Joseph Cannova, Emily Dworkin, et al.
British Journal of Haematology|November 17, 2024
Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasmsEmily O Symes, Peng Wang, Payal Sojitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic SyndromeElizabeth A Griffiths, Pragya Srivastava, Junko Matsuzaki, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Genetic Counseling|January 15, 2023
Stagnation in quality of next-generation sequencing assays for the diagnosis of hereditary hematopoietic malignanciesGregory W Roloff, Reid Shaw, Timothy E O'Connor, et al.
Leukemia & Lymphoma|June 9, 2023
Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromesAdam Hamidi, Gregory W Roloff, Reid Shaw, et al.
Molecular Biology of the Cell|November 14, 2015
Locus-specific gene repositioning in prostate cancerMarc Leshner, Michelle Devine, Gregory W Roloff, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 6, 2022
Contemporary Approach to Acute Myeloid Leukemia Therapy in 2022Gregory W Roloff, Olatoyosi Odenike, Ashish Bajel, et al.
Haematologica|September 2, 2018
Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemiaLaura W Dillon, Sheida Hayati, Gregory W Roloff, et al.
Histochemistry and Cell Biology|January 22, 2016
Tissue-of-origin-specific gene repositioning in breast and prostate cancerKaren J Meaburn, Olufunmilayo Agunloye, Michelle Devine, et al.
Frontiers in Oncology|July 3, 2023
Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantationReid Shaw, Ali R Haque, Tyler Luu, et al.
Ejhaem|June 16, 2025
Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax TherapyRafael Madero-Marroquin, Joseph Cannova, Emily Dworkin, et al.
British Journal of Haematology|November 17, 2024
Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasmsEmily O Symes, Peng Wang, Payal Sojitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic SyndromeElizabeth A Griffiths, Pragya Srivastava, Junko Matsuzaki, et al.
Pageof 4